Neuralink's Blindsight Vision Chip Set for Human Implantation by 2025
Blindsight and Neuralink: A New Era in Vision Restoration
Musk’s Neuralink is gearing up for a significant milestone: the first human implantation of the Blindsight vision chip by the end of 2025. This innovative chip is designed to enhance visual processing in individuals with severe vision impairments. The FDA granted the Blindsight chip a breakthrough designation in September, a recognition that underscores its potential to change lives.
What is Blindsight?
Blindsight is an advanced neurological concept where a person can respond to visual stimuli without conscious awareness of seeing. Neuralink's technology aims to tap into this phenomenon by using a brain chip to restore vision.
Impact of Neuralink's Breakthrough
- Enhancement of visual capabilities in non-functional visual pathways.
- Restoration of autonomy in affected individuals.
- Potential to pave the way for future neural-based therapies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.